Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CA–SP1 cleavage site is a specific region within the HIV-1 Gag polyprotein, located between the capsid protein (CA) and spacer peptide 1 (SP1). This site is crucial for viral maturation, as it is the target of the final proteolytic cleavage by the viral protease during HIV-1 particle maturation. Cleavage at this site triggers a major structural rearrangement essential for infectivity, making it an attractive target for maturation inhibitors.
Stabilization of the CA-SP1 six-helix bundle, preventing HIV protease access and blocking cleavage at the CA-SP1 junction.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capsid protein (CA)–Spacer Peptide 1 (SP1) cleavage site (CA-SP1 cleavage site).